Comparison of performance of ADXBLADDER with urine cytology in NMIBC follow up: a blinded prospective multicentric study

by P. Gontero, F. Longo, M. Allasia, M. Roupret, J. Stockley, A. Kennedy, O. Rodriguez, C. Sieverink, F. Vanie, J. Witjes, M. Colombel, S. McCracken, T. Dudderidge, R. Sylvester, J. Palou, E. Montanari
Published 2020-10-01

Diagnostic performance of MCM5 testing in the diagnosis of recurrent bladder cancer: Results from a large prospective, blinded, multicentric European study

by M. Rouprêt, P. Gontero, S. McCracken, T. Dudderidge, J. Stockley, A. Kennedy, Ó. Rodríguez, C. Sieverink, F. Vanié, M. Allasia, J.A. Witjes, M. Colombel, R. Sylvester, F. Longo, E. Montanari, J. Palou
Published 2020-07-01

Evaluation of ADXBLADDER and cytology performance in the follow up of NMIBC: A blinded prospective multicentric study

by P. Gontero, E. Montanari, M. Roupret, F. Longo, J. Stockley, A. Kennedy, Ó. Rodríguez, C. Sieverink, F. Vanié, M. Allasia, J.A. Witjes, M. Colombel, R. Sylvester, S. McCracken, T. Dudderidge, J. Palou
Published 2020-07-01

Diagnostic performance of MCM5 testing in the diagnosis of recurrent bladder cancer: results from a large prospective, blinded, multicentric european study

by E. Montanari, F. Longo, P. Gontero, M. Roupret, J. Stockley, A. Kennedy, O.Rodriguez Faba, C. Sieverink, M. Allasia, F. Vaniè, J.A. Witjes, M. Colombel, R. Sylvester, S. McCracken, T. Dudderidge, J. Palou
Published 2020-10-01